Detailed Information
Cited 151 time in 
Cited 170 time in 
Cited 170 time in
Metadata Downloads
Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Hyun Soo | - |
| dc.contributor.author | Park, Chan Bae | - |
| dc.contributor.author | Kim, Jung Min | - |
| dc.contributor.author | Jang, Su A. | - |
| dc.contributor.author | Park, In Yup | - |
| dc.contributor.author | Kim, Mi Sun | - |
| dc.contributor.author | Cho, Ju Hyun | - |
| dc.contributor.author | Kim, Sun Chang | - |
| dc.date.accessioned | 2022-12-27T06:02:35Z | - |
| dc.date.available | 2022-12-27T06:02:35Z | - |
| dc.date.issued | 2008-11-18 | - |
| dc.identifier.issn | 0304-3835 | - |
| dc.identifier.issn | 1872-7980 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/27217 | - |
| dc.description.abstract | Buforin IIb is a novel cell-penetrating anticancer peptide derived from histone H2A. Here we analyzed the anticancer activity and cancer cell-killing mechanism of buforin IIb. Buforin IIb displayed selective cytotoxicity against 62 cancer cell lines by specifically targeting cancer cells through interaction with cell surface gangliosides. It traversed cancer cell membranes without damaging them and accumulated primarily in the nuclei. Once inside the cells, buforin IIb induced mitochondria-dependent apoptosis. In vivo analysis revealed that buforin IIb displayed significant tumor suppression activity in mice with tumor xenograft. Overall, these results suggest that buforin IIb constitutes a novel therapeutic agent for the treatment of cancers. (C) 2008 Elsevier Ireland Ltd. All rights reserved. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER IRELAND LTD | - |
| dc.title | Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide | - |
| dc.type | Article | - |
| dc.publisher.location | 아일랜드 | - |
| dc.identifier.doi | 10.1016/j.canlet.2008.05.041 | - |
| dc.identifier.scopusid | 2-s2.0-53049110294 | - |
| dc.identifier.wosid | 000260987900005 | - |
| dc.identifier.bibliographicCitation | CANCER LETTERS, v.271, no.1, pp 47 - 55 | - |
| dc.citation.title | CANCER LETTERS | - |
| dc.citation.volume | 271 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 47 | - |
| dc.citation.endPage | 55 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | HOST-DEFENSE PEPTIDES | - |
| dc.subject.keywordPlus | ANTIMICROBIAL PEPTIDE | - |
| dc.subject.keywordAuthor | Anticancer peptide | - |
| dc.subject.keywordAuthor | Buforin IIb | - |
| dc.subject.keywordAuthor | Ganglioside | - |
| dc.subject.keywordAuthor | Histone H2A | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.